Purulent pericarditis after percutaneous coronary intervention： A case report and literature review

doi:10.3969/j.issn.1004-583X.2025.12.009

Abstract

Abstract:

Objective To describe the clinical presentation，diagnostic workup，and management of purulent pericarditis occurring after percutaneous coronary intervention （PCI），and to summarize relevant literature to provide clinical guidance. Methods We performed a retrospective case analysis of a patient who developed purulent pericarditis after PCI and conducted a targeted review of published reports on post PCI purulent pericarditis. Results An elderly male with a long history of intermittent chest tightness for over 20 years presented with worsening chest pain for 4 days. PCI had been performed shortly before symptom onset. Significant comorbidities included advanced age，diabetes mellitus，and recent herpes zoster infection. Transthoracic echocardiography and chest CT revealed a pericardial effusion. The patient underwent pericardiocentesis drainage，pericardial lavage with saline and antibiotics，and systemic intravenous antibiotics，resulting in clinical improvement. At one month outpatient follow up，the patient was clinically well，and echocardiography showed resolution of the effusion. Conclusion Prompt recognition，pericardial drainage，and early，aggressive antimicrobial therapy are crucial for favorable outcomes of purulent pericarditis.

Key words: suppurative pericarditis, pericardial effusion, percutaneous coronary intervention

CLC Number:

R542.11

Wang Jiaqi, Xie Yuetao, Liu Huiliang, Zhang Feifei, Dang Yi, Li Yingxiao, Qi Xiaoyong. Purulent pericarditis after percutaneous coronary intervention： A case report and literature review[J]. Clinical Focus, 2025, 40(12): 1104-1107.

Add to citation manager EndNote|Ris|BibTeX

URL: https://www.lchc.cn/EN/10.3969/j.issn.1004-583X.2025.12.009

https://www.lchc.cn/EN/Y2025/V40/I12/1104

Figures/Tables 4

References 10

[1]	Christian-Miller N, Goraya S, O'Hayer P, et al. Purulent streptococcus intermedius pericarditis in the setting of histoplasma mediastinal lymphadenitis: A case report and literature review[J]. Cureus, 2024, 16(6):e62626. doi:10.7759/cureus.62626.
[2]	Vara P, Urassa D, Temba B, et al. Chronic purulent pericarditis: Case report[J]. Pan Afr Med J, 2022, 42:145.doi: 10.11604/pamj.2022.42.145.34018. pmid: 36160276
[3]	Li YM, Jia YH, Tsauo JY, et al. Case report: ST-segment elevation in a man with acute pericarditis[J]. Front Cardiovasc Med, 2020, 7:609691.doi: 10.3389/fcvm.2020.609691.
[4]	Cai Q. Streptococcus anginosus purulent pericarditis with cardiac tamponade after coronary artery bypass surgery[J]. BMJ Case Rep, 2020, 13(8):e235862.doi: 10.1136/bcr-2020-235862.
[5]	Oizumi H, Ichinokawa H, Hoshino H, et al. Pericardial window for methicillin-resistant staphylococcus aureus pericarditis[J]. Ann Thorac Surg, 2019, 107(1):e27-e29. doi: 10.1016/j.athoracsur.2018.05.053.
[6]	Ganji M, Ruiz J, Kogler W, et al. Methicillin-resistant staphylococcus aureus pericarditis causing cardiac tamponade[J]. IDCases, 2019, 18:e00613. doi: 10.1016/j.idcr.2019.e00613.
[7]	Kapacinskaité M, Gabartaité D, Šatrauskiené A, et al. A rare case of primary purulent pericarditis caused by streptococcus constellatus[J]. Medicina (Kaunas), 2023, 59(1):159. doi: 10.3390/medicina59010159.
[8]	Riku S, Suzuki S, Jinno Y, et al. Coronary drug-eluting stent infection complicated by coronary artery aneurysm and purulent pericarditis:Complete resolution without surgery[J]. Can J Cardiol, 2020, 36(6):967.e1-967.e3. doi:10.1016/j.cjca.2020.01.007.
[9]	Lin Z, Liang X, Zhang Y, et al. Positive association between stress hyperglycemia ratio and pulmonary infection in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention[J]. Cardiovasc Diabetol, 2023, 22(1):76. doi:10.1186/s12933-023-01799-3.
[10]	赵文利, 贾晓辉, 张建红, 等. 急性心肌梗死患者急诊冠脉介入治疗术后医院感染病原学分析[J]. 中华医院感染学杂志, 2017, 27(8):1736-1738+1742. doi:10.11816/cn.ni.2017-163462.

[1]	Liu Ping, Yu Meng, Liu Mingxin, Li Wenfeng. Correlation of new inflammatory indicators in the complete blood count with major adverse cardiovascular events in patients with acute anterior wall ST-segment elevation myocardial infarction after percutaneous coronary intervention [J]. Clinical Focus, 2025, 40(5): 400-407.
[2]	Zhang Lei, Li Xin, Guo Zhenfeng. Efficacy and safety of intracoronary injection of teneplase versus tirofiban on the treatment of acute ST-segment elevation myocardial infarction [J]. Clinical Focus, 2024, 39(7): 598-602.
[3]	Li Yanan, Zhang Hongyu. Clinical study of the efficacy of intracoronary injections of low-dose prourokinase through the tail of the balloon on acute ST-segment elevation myocardial infarction patients undergoing percuteneous coronary intervention [J]. Clinical Focus, 2024, 39(6): 518-523.
[4]	Song Jinfang, Song Hang, Song Shiyi, Tian Xin. Childhood eosinophilic gastroenteritis with multiple serous cavity effusion: A case report and literature review [J]. Clinical Focus, 2023, 38(6): 544-549.
[5]	Yan Haiyan, Ding Yankui, JiaHongjing , WangJiyuan , Zhang Xuewei, Hu Yinjie, Chu Junjie, Hu Hongyan, Guo Gaofeng. Correlation of pre-hospital heparinization combined with one pack of drugs and revascularization in patients with acute ST-segment elevation myocardial infarction [J]. Clinical Focus, 2023, 38(3): 232-236.
[6]	Wang Jiaqi, Gao Man, Zhang Feifei, Li Yingxiao, Dang Yi, Qi Xiaoyong. Predicting value of neutrophil to lymphocyte ratio combined with GRACE score on in-hospital major adverse cardiovascular events of postoperative PCI in acute STEMI patients [J]. Clinical Focus, 2022, 37(5): 412-417.
[7]	Deng Kaibin, Han Liang, Niu Shaoqian, Wang Haiyan, Wang Yanbo, Fu Yang, Wang Qing, Zhan Yang, Fu Xianghua. Effect of optimized treatment approach on acute STEMI patients under the situation of prevention and control of COVID-19 [J]. Clinical Focus, 2021, 36(7): 595-599.
[8]	Shi Jun, Liu Xinbing, Bai Yanyan, Yue Dandan, Wang Xiaoqing, Liu Tianhua, Feng Liuliu. Influencing factors of myocardial microcirculation perfusion disorder after percutaneous coronary intervention in acute myocardial infarction and relationship with lactic acid [J]. Clinical Focus, 2021, 36(5): 402-407.
[9]	Zhou Jing, Dai Yunlang. Clinical characteristics and prognosis of patients with isolated left main stenosis in coronary intervention [J]. Clinical Focus, 2021, 36(1): 12-15.
[10]	Luo Kaifeng, Feng Chuanjie. The factors influencing the prognosis of STsegment elevation myocardial infarction after coronary intervention A meta analysis [J]. Clinical Focus, 2020, 35(12): 1067-1077.
[11]	Liu Jinming， Li Fang， Xie Yanan. Progress in treatment strategies of patients with acute coronary [J]. Clinical Focus, 2016, 31(6): 600-605.
[12]	Yao Haimu;Shen Deliang;Fu Xin;Zhao Xiaoyan;Wang Xiaofang;Zhang Jinying;Li Ling. Prognostic value of red cell distribution width for patients treated with drug-eluting stent [J]. Clinical Focus, 2015, 30(8): 919-923.
[13]	Quan Feng;Fan Xuemei;Fang Wenlong. Clinical study of systemic lupus erythematosus associated pulmonary hypertension [J]. Clinical Focus, 2015, 30(12): 1402-1.40414e+007.
[14]	Mi Tao;Quan Xiaoqing;Qiao Lifen;Zhou Honglian. Analysis of percutaneous coronary intervention in elderly patients with chronic total occlusion [J]. Clinical Focus, 2015, 30(12): 1356-1359.
[15]	. Impact of triple anti-platelet therapy on activation of platelet and short-term outcomes in CHD patients with diabetes undergoing PCI [J]. Clinical Focus, 2014, 29(12): 1334-1338.